146 related articles for article (PubMed ID: 22468993)
1. Stereotactic radiotherapy for malignancies involving the trigeminal and facial nerves.
Cuneo KC; Zagar TM; Brizel DM; Yoo DS; Hoang JK; Chang Z; Wang Z; Yin FF; Das SK; Green S; Ready N; Bhatti MT; Kaylie DM; Becker A; Sampson JH; Kirkpatrick JP
Technol Cancer Res Treat; 2012 Jun; 11(3):221-8. PubMed ID: 22468993
[TBL] [Abstract][Full Text] [Related]
2. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
3. Novalis intensity-modulated radiosurgery: methods for pretreatment planning.
Jensen RL; Wendland MM; Chern SS; Shrieve DC
Neurosurgery; 2008 May; 62(5 Suppl):A2-9; discussion A9-10. PubMed ID: 18580777
[TBL] [Abstract][Full Text] [Related]
4. Improved trigeminal and facial nerve tolerance following fractionated stereotactic radiotherapy for large acoustic neuromas.
Kalapurakal JA; Silverman CL; Akhtar N; Andrews DW; Downes B; Thomas PR
Br J Radiol; 1999 Dec; 72(864):1202-7. PubMed ID: 10703478
[TBL] [Abstract][Full Text] [Related]
5. Linear accelerator stereotactic radiosurgery for vestibular schwannomas: a UK series.
Benghiat H; Heyes G; Nightingale P; Hartley A; Tiffany M; Spooner D; Geh JI; Cruickshank G; Irving RM; Sanghera P
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):309-15. PubMed ID: 24636634
[TBL] [Abstract][Full Text] [Related]
6. [First experience of stereotactic radiation therapy for vestibular schwannoma using CyberKnife].
Zolotova SV; Golanov AV; Trunin IuIu; Galkin MV; Kotel'nikova TM; Antipina NA; Gorlachev GE; Nikonova NG; Pronin IN
Zh Vopr Neirokhir Im N N Burdenko; 2012; 76(1):13-20; discussion 20. PubMed ID: 22629843
[TBL] [Abstract][Full Text] [Related]
7. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
Combs SE; Adeberg S; Dittmar JO; Welzel T; Rieken S; Habermehl D; Huber PE; Debus J
Radiother Oncol; 2013 Feb; 106(2):186-91. PubMed ID: 22906549
[TBL] [Abstract][Full Text] [Related]
8. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of nonacoustic cranial nerve schwannomas.
Showalter TN; Werner-Wasik M; Curran WJ; Friedman DP; Xu X; Andrews DW
Neurosurgery; 2008 Oct; 63(4):734-40; discussion 740. PubMed ID: 18981884
[TBL] [Abstract][Full Text] [Related]
10. Tolerance of cranial nerves of the cavernous sinus to radiosurgery.
Tishler RB; Loeffler JS; Lunsford LD; Duma C; Alexander E; Kooy HM; Flickinger JC
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):215-21. PubMed ID: 8407394
[TBL] [Abstract][Full Text] [Related]
11. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiotherapy for intracranial nonacoustic schwannomas including facial nerve schwannoma.
Nishioka K; Abo D; Aoyama H; Furuta Y; Onimaru R; Onodera S; Sawamura Y; Ishikawa M; Fukuda S; Shirato H
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1415-9. PubMed ID: 19386429
[TBL] [Abstract][Full Text] [Related]
13. Gamma knife radiosurgery in younger patients with vestibular schwannomas.
Lobato-Polo J; Kondziolka D; Zorro O; Kano H; Flickinger JC; Lunsford LD
Neurosurgery; 2009 Aug; 65(2):294-300; discussion 300-1. PubMed ID: 19625908
[TBL] [Abstract][Full Text] [Related]
14. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated fractionated stereotactic radiotherapy with reduced margin for high grade gliomas: dosimetric analysis of sparing optic nerve & chiasm.
Koh HK; Kim CY; Han JH; Kim YJ; Kim HJ; Kim JS; Kim IA
J Radiosurg SBRT; 2013; 2(4):307-314. PubMed ID: 29296373
[TBL] [Abstract][Full Text] [Related]
16. Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome.
Combs SE; Schulz-Ertner D; Moschos D; Thilmann C; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):814-9. PubMed ID: 15936565
[TBL] [Abstract][Full Text] [Related]
17. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients.
Morita A; Coffey RJ; Foote RL; Schiff D; Gorman D
J Neurosurg; 1999 Jan; 90(1):42-9. PubMed ID: 10413154
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of fractionated stereotactic radiotherapy for acoustic neuromas.
McClelland S; Gerbi BJ; Higgins PD; Orner JB; Hall WA
J Neurooncol; 2008 Jan; 86(2):191-4. PubMed ID: 17622486
[TBL] [Abstract][Full Text] [Related]
19. Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas.
Bugoci DM; Girvigian MR; Chen JC; Miller MM; Rahimian J
Am J Clin Oncol; 2013 Aug; 36(4):404-10. PubMed ID: 22772429
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy.
McClelland S; Higgins PD; Gerbi BJ; Orner JB; Hall WA
Technol Cancer Res Treat; 2007 Jun; 6(3):177-80. PubMed ID: 17535025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
